John C Lieske

University Of Chicago

$18,323,845

Attributed

$19,620,124

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$27,433,168 · 23

By mechanism

U54$9,596,292 · 6

P50$5,280,349 · 1

R01$5,154,689 · 3

P20$2,493,813 · 5

T32$2,305,648 · 1

R21$1,989,748 · 5

Top collaborators

Peter C. Harris6 shared
William Ricke1 shared

Most similar at University Of Chicago

Same institution · by research overlap

Bana Jabri$21,767,484

Others in their field

Top investigators on “Nephrolithiasis”

Joseph R Hume · University Of Nevada Reno$9,222,880
Naim M Maalouf · University Of Texas Sw Med Ctr/Dallas$8,011,787
Lawrence John Appel · Johns Hopkins University$7,762,016
Khashayar Sakhaee · University Of Texas Sw Med Ctr/Dallas$6,566,285
Gary C. Curhan · Brigham And Women'S Hospital$5,125,178
Andrew P Evan · Indiana Univ-Purdue Univ At Indianapolis$5,079,076

Research focus

NephrolithiasisPhenotypeKidney CalculiMultidisciplinaryResearch PersonnelOxalatesClinicUrinary CalculiAffectCrystallizationFutureUrinaryResourcesUrologyPathogenesisCalculiPainCalciumLesionUrineRecurrenceEventCostHypercalciuria

Grant awards (95)

An individualized medicine approach to urinary stone disease$536,417

R01 · FY2025 · DK · contact PI

Next Generation KUH Researchers (GENERATOR)$368,742

U2C · FY2025 · DK · contact PI

Next Generation KUH Researchers (GENERATOR) Admin Core$243,887

U2C · FY2025 · DK · contact PI

An individualized medicine approach to urinary stone disease$514,961

R01 · FY2024 · DK · contact PI

Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice$395,264

P20 · FY2024 · DK · contact PI

Research Project$355,514

P20 · FY2024 · DK · contact PI

Admin Core$159,825

P20 · FY2024 · DK · contact PI

An individualized medicine approach to urinary stone disease$552,665

R01 · FY2023 · DK · contact PI

Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice$394,105

P20 · FY2023 · DK · contact PI

Research Project$354,355

P20 · FY2023 · DK · contact PI

Kidney Disease Research Training Program$240,417

T32 · FY2023 · DK · contact PI

Admin Core$39,750

P20 · FY2023 · DK · contact PI

An individualized medicine approach to urinary stone disease$551,266

R01 · FY2022 · DK · contact PI

Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice$397,500

P20 · FY2022 · DK · contact PI

Research Project$357,750

P20 · FY2022 · DK · contact PI

Kidney Disease Research Training Program$217,667

T32 · FY2022 · DK · contact PI

Admin Core$39,750

P20 · FY2022 · DK · contact PI

Facilitating personalized medicine of monogenic stone patients by genetic characterization$198,750

R21 · FY2021 · TR

Kidney Disease Research Training Program$165,403

T32 · FY2021 · DK · contact PI

Facilitating personalized medicine of monogenic stone patients by genetic characterization$238,500

R21 · FY2020 · TR

Kidney Disease Research Training Program$221,498

T32 · FY2020 · DK · contact PI

Kidney Disease Research Training Program$207,808

T32 · FY2019 · DK · contact PI

Kidney Disease Research Training Program$172,273

T32 · FY2018 · DK · contact PI

Improving stone disease treatment by accurate phenotyping and risk stratification$1,000,000

U54 · FY2017 · DK · contact PI

Kidney Disease Research Training Program$180,607

T32 · FY2017 · DK · contact PI

NEPHROLITHIASIS PHENONOTYPING AND BIOBANK CORE$103,605

U54 · FY2017 · DK · contact PI

VISUALIZATION AND PATHOPHYSIOLOGY OF RENAL STONE PRECURSOR LESIONS$102,740

U54 · FY2017 · DK · contact PI

Improving stone disease treatment by accurate phenotyping and risk stratification$100,000

U54 · FY2017 · DK · contact PI

Administrative Core$61,232

U54 · FY2017 · DK · contact PI

Kidney Disease Research Training Program$8,879

T32 · FY2017 · DK · contact PI

Improving stone disease treatment by accurate phenotyping and risk stratification$999,998

U54 · FY2016 · DK · contact PI

NEPHROLITHIASIS PHENONOTYPING AND BIOBANK CORE$136,613

U54 · FY2016 · DK · contact PI

Kidney Disease Research Training Program$133,554

T32 · FY2016 · DK · contact PI

Improving stone disease treatment by accurate phenotyping and risk stratification$103,761

U54 · FY2016 · DK · contact PI

VISUALIZATION AND PATHOPHYSIOLOGY OF RENAL STONE PRECURSOR LESIONS$102,659

U54 · FY2016 · DK · contact PI

Administrative Core$61,210

U54 · FY2016 · DK · contact PI

Improving stone disease treatment by accurate phenotyping and risk stratification$999,999

U54 · FY2015 · DK · contact PI

Kidney Disease Research Training Program$166,718

T32 · FY2015 · DK · contact PI

NEPHROLITHIASIS PHENONOTYPING AND BIOBANK CORE$140,984

U54 · FY2015 · DK · contact PI

VISUALIZATION AND PATHOPHYSIOLOGY OF RENAL STONE PRECURSOR LESIONS$100,425

U54 · FY2015 · DK · contact PI

Administrative Core$59,854

U54 · FY2015 · DK · contact PI

Improving stone disease treatment by accurate phenotyping and risk stratification$53,676

U54 · FY2015 · DK · contact PI

Improving stone disease treatment by accurate phenotyping and risk stratification$999,999

U54 · FY2014 · DK · contact PI

Kidney Disease Research Training Program$156,335

T32 · FY2014 · DK · contact PI

NEPHROLITHIASIS PHENONOTYPING AND BIOBANK CORE$146,170

U54 · FY2014 · DK · contact PI

VISUALIZATION AND PATHOPHYSIOLOGY OF RENAL STONE PRECURSOR LESIONS$96,090

U54 · FY2014 · DK · contact PI

Administrative Core$57,271

U54 · FY2014 · DK · contact PI

Improving stone disease treatment by accurate phenotyping and risk stratification$2,000,000

U54 · FY2013 · DK · contact PI

NEPHROLITHIASIS PHENONOTYPING AND BIOBANK CORE$281,628

U54 · FY2013 · DK · contact PI

Defining the natural history and treatment options for Dent Disease$191,568

U54 · FY2013 · DK · contact PI

VISUALIZATION AND PATHOPHYSIOLOGY OF RENAL STONE PRECURSOR LESIONS$185,141

U54 · FY2013 · DK · contact PI

Administrative Core$110,345

U54 · FY2013 · DK · contact PI

Pilot and Feasibility Program$108,875

U54 · FY2013 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$983,060

P50 · FY2012 · DK · contact PI

Defining the natural history and treatment options for Dent Disease$212,474

U54 · FY2012 · DK · contact PI

Kidney Disease Research Training Program$139,719

T32 · FY2012 · DK · contact PI

Pilot and Feasibility Program$93,703

U54 · FY2012 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$51,840

P50 · FY2012 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$983,060

P50 · FY2011 · DK · contact PI

Genetic determinants of urine lithogenicity$432,727

R01 · FY2011 · DK · contact PI

Defining the natural history and treatment options for Dent Disease$235,674

U54 · FY2011 · DK · contact PI

Kidney Disease Research Training Program$180,462

T32 · FY2011 · DK · contact PI

Pilot and Feasibility Program$92,511

U54 · FY2011 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$38,880

P50 · FY2011 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$983,060

P50 · FY2010 · DK · contact PI

Genetic determinants of urine lithogenicity$514,784

R01 · FY2010 · DK · contact PI

Defining the natural history and treatment options for Dent Disease$239,436

U54 · FY2010 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$181,320

P50 · FY2010 · DK · contact PI

Kidney Disease Research Training Program$114,308

T32 · FY2010 · DK · contact PI

Pilot and Feasibility Program$93,256

U54 · FY2010 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$64,209

P50 · FY2010 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$28,800

P50 · FY2010 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$983,060

P50 · FY2009 · DK · contact PI

Genetic determinants of urine lithogenicity$408,198

R01 · FY2009 · DK · contact PI

Defining the natural history and treatment options for Dent Disease$225,810

U54 · FY2009 · DK · contact PI

Genetic determinants of urine lithogenicity$100,783

R01 · FY2009 · DK · contact PI

Pilot and Feasibility Program$99,585

U54 · FY2009 · DK · contact PI

Mayo Clinic Urology O'Brien Research Center$983,060

P50 · FY2008 · DK · contact PI

Genetic determinants of urine lithogenicity$344,660

R01 · FY2008 · DK · contact PI

Use of symbiotics to reduce urinary oxalate excretion$214,354

R21 · FY2007 · AT · contact PI

Nephrolithiasis and Chronic Kidney Disease$210,125

R21 · FY2007 · DK · contact PI

Nephrolithiasis and Chronic Kidney Disease$182,227

R21 · FY2006 · DK · contact PI

Use of symbiotics to reduce urinary oxalate excretion$180,261

R21 · FY2006 · AT · contact PI

Use of symbiotics to reduce urinary oxalate excretion$184,531

R21 · FY2005 · AT

NOVEL INHIBITOR OF CRYSTAL ADHESION TO RENAL CELLS$197,536

R01 · FY2004 · DK

Role of Nanobacteria in Human Calcifying Disease$146,000

R21 · FY2004 · DK

NOVEL INHIBITOR OF CRYSTAL ADHESION TO RENAL CELLS$209,933

R01 · FY2003 · DK

NOVEL INHIBITOR OF CRYSTAL ADHESION TO RENAL CELLS$187,111

R01 · FY2003 · DK

Role of Nanobacteria in Human Calcifying Disease$146,000

R21 · FY2003 · DK

Oxalate-Induced Renal Scarring and Crystal Retention$144,500

R21 · FY2003 · DK

NOVEL INHIBITOR OF CRYSTAL ADHESION TO RENAL CELLS$203,576

R01 · FY2002 · DK

Oxalate-Induced Renal Scarring and Crystal Retention$144,500

R21 · FY2002 · DK

NOVEL INHIBITOR OF CRYSTAL ADHESION TO RENAL CELLS$195,195

R01 · FY2001 · DK

NOVEL INHIBITOR OF CRYSTAL ADHESION TO RENAL CELLS$204,847

R01 · FY2000 · DK

NOVEL INHIBITOR OF CRYSTAL ADHESION TO RENAL CELLS$30

R01 · FY2000 · DK